RH Bophelo (JSE:RHB) EBIT: R26.96 Mil (TTM As of Feb. 2026)

What is RH Bophelo EBIT?

RH Bophelo JSE:RHB 70 EBIT is R26.96 Mil as of Feb. 2026. GuruFocus rates JSE:RHB with a GF Score™ of 70/100 and a GF Value™ of R6.13 (Possible Value Trap). The stock has 4 warning signs investors should review.

RH Bophelo's earnings before interest and taxes (EBIT) for the six months ended in Feb. 2026 was R-3.54 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Feb. 2026 was R26.96 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. RH Bophelo's annualized ROC % for the quarter that ended in Feb. 2026 was 0.56%. RH Bophelo's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was -222.38%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. RH Bophelo's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was 25.14%.

RH Bophelo (JSE:RHB) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

RH Bophelo's annualized ROC % for the quarter that ended in Feb. 2026 is calculated as:

	ROC % (Q: Feb. 2026 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Aug. 2025 )	+	Invested Capital (Q: Feb. 2026 ))	/ count )
=	146.97 * ( 1 - 95.16% )	/	( (1314.9	+	1233.472)	/ 2 )
=	7.113348	/	1274.186
=	0.56 %

where

	Invested Capital		(Q: Aug. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1327.607	-	12.228	-	( 29.485	-	max(0, 38.338	-	38.817	+	29.485	))
=	1314.9

	Invested Capital		(Q: Feb. 2026 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1258.638	-	14.968	-	( 27.235	-	max(0, 41.81	-	52.008	+	27.235	))
=	1233.472

Note: The Operating Income data used here is two times the semi-annual (Feb. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

RH Bophelo's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Feb. 2026 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Aug. 2025		Q: Feb. 2026
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-7.086	/	( ( (3.599 + max(-10.678, 0))	+	(2.774 + max(-12.985, 0)) )	/	2 )
=	-7.086	/	( ( 3.599	+	2.774 )	/	2 )
=	-7.086	/	3.1865
=	-222.38 %

where Working Capital is:

	Working Capital		(Q: Aug. 2025 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	1.55)	-	(12.228	+	0	+	0)
=	-10.678

	Working Capital		(Q: Feb. 2026 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	2.69)	-	(14.968	+	0	+	0.707)
=	-12.985

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Feb. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

RH Bophelo's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Feb. 2026 )
	=	26.962	/	107.257
	=	25.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RH Bophelo EBIT Related Terms

RH Bophelo EBIT Historical Data

* Premium members only.

The historical data trend for RH Bophelo's EBIT can be seen below:

RH Bophelo EBIT Chart

RH Bophelo Annual Data

Trend

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Feb25

Feb26

EBIT

Get a 7-Day Free Trial

64.67

-37.39

252.33

71.56

26.96

RH Bophelo Semi-Annual Data
	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24	Aug24	Feb25	Aug25	Feb26
EBIT	Get a 7-Day Free Trial														215.76	33.87	37.70	30.51	-3.54

JSE:RHB vs BLK, BX, KKR: EBIT Comparison

For the Asset Management subindustry, RH Bophelo's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RH Bophelo EV-to-EBIT vs Asset Management Industry

For the Asset Management industry and Financial Services sector, RH Bophelo's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where RH Bophelo's EV-to-EBIT falls into.

Save Embed

70GF Score

RH Bophelo Ltd JSE:RHB

EBIT is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

RH Bophelo EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was R26.96 Mil.

Frequently Asked Questions Learn more about EBIT →

What does a EBIT of R26.96 Mil mean?

RH Bophelo (JSE:RHB) has a EBIT of R26.96 Mil as of Feb. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on RH Bophelo.

Is RH Bophelo's EBIT too high?

RH Bophelo's current EBIT is R26.96 Mil. Overall, RH Bophelo has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does RH Bophelo's EBIT compare to BLK and BX?

RH Bophelo's EBIT of R26.96 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT for an Asset Management company?

A good EBIT depends on the Asset Management industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT mean?

A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on RH Bophelo. RH Bophelo's current EBIT is R26.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is RH Bophelo stock overvalued right now?

Based on GuruFocus' analysis, RH Bophelo (JSE:RHB) is currently considered Possible Value Trap. The stock's GF Value™ is R6.13, compared to a current price of R1.65 — trading 73.1% below its estimated fair value. The current EBIT is R26.96 Mil. RH Bophelo's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT calculated?

EBIT is calculated from a company's financial statements. For RH Bophelo (JSE:RHB), the current EBIT is R26.96 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RH Bophelo (JSE:RHB) Overvalued in 2026?

Based on GuruFocus' analysis, RH Bophelo stock appears to be undervalued. The current stock price of R1.65 is trading 73.1% below its estimated GF Value™ of R6.13. GuruFocus considers RH Bophelo to be Possible Value Trap.

Key valuation signals for JSE:RHB:

EBIT: R26.96 Mil
GF Value™: R6.13 vs. price of R1.65 (73.1% below fair value)
GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the JSE:RHB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RH Bophelo Business Description

Industry Financial Services Asset Management

Comparable Companies JSE:BAC JSE:HUG JSE:GRSP JSE:MHB BLK BX OSTO:INVE A TSX:BN KKR TSX:BAM APO STT OSTO:EQT AMP LSE:III NTRS ARES RJF XSWX:PGHN OSTO:INDU A

Address 1, Melrose Boulevard, Unit 12, 1st Floor, Melrose Arch, Johannesburg, GT, ZAF, 2191

Website https://www.rhbophelo.co.za

RH Bophelo Ltd is a healthcare investment company. Its main business involves the acquisition of healthcare assets in commercial entities or special situations across the South African market. It is engaged in making equity, quasi-equity, and equity-related investments in healthcare and financial sectors, specifically in operational infrastructure, health insurance, private hospital infrastructure, pharmaceuticals, retail and distribution, and healthcare technology. The company's operating segments are the Healthcare segment and the Financial Services segment. The majority of its revenue is generated from the Healthcare segment, which focuses on making investments in healthcare infrastructure, healthcare technology, and property companies.

70GF Score

Get the complete analysis for JSE:RHB

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R1.65

Price

R6.13

GF Value

View JSE:RHB Analysis

See EBIT data for all stocks →